Back to search

Article

The Potential Clinical Impact of Implementing Different COVID-19 Boosters in Fall 2022 in the United States

2022-07-22

Abstract excerpt

<h4>Objective</h4> Emerging SARS-COV-2 variants are spurring the development of adapted vaccines as public health authorities plan for the fall vaccination strategy. We aimed to estimate the number of infections and hospitalizations prevented by three potential booster strategies in those ≥18 years of age in the United States: Boosting with Moderna’s licensed first generation monovalent vaccine mRNA-1273 (ancestra...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e038df0f-e17f-5871-aa76-7d2057c2b438
DOI
10.1101/2022.07.19.22277824
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Potential Clinical Impact of Implementing Different COVID-19 Boosters in Fall 2022 in the United StatesDOI 10.1101/2022.07.19.22277824
The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA Fall 2023 vaccines in the United StatesSemantic proximity
Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: a multi-model studySemantic proximity
COVID-19 deaths and hospitalizations averted by rapid vaccination rollout in the United StatesSemantic proximity
Projected resurgence of COVID-19 in the United States in July—December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccinationSemantic proximity
Impact of the additional/booster dose of COVID-19 vaccine against severe disease during the epidemic phase characterized by the predominance of the Omicron variant in Italy, December 2021 - May 2022Semantic proximity
Effectiveness of the 2023-2024 Omicron XBB.1.5-containing mRNA COVID-19 vaccine (mRNA-1273.815) in preventing COVID-19-related hospitalizations and medical encounters among adults in the United States: An interim analysisSemantic proximity
Association between COVID-19 mRNA vaccination and COVID-19 illness and severity during Omicron BA.4 and BA.5 sublineage periodsSemantic proximity
Forecasting the Trajectory of the COVID-19 Pandemic under Plausible Variant and Intervention Scenarios: A Global Modelling StudySemantic proximity
Effectiveness of Mrna Booster Vaccination Against Mild and Severe COVID-19 During Delta and Omicron Variant Circulation in Germany: An Analysis of National Surveillance DataSemantic proximity
Immunogenicity and Safety of COVID-19 Booster Vaccination: A Real-World Clinical Trial to Identify the Best Vaccination StratagySemantic proximity
Impact of accelerating booster vaccination amidst Omicron surge in the United StatesSemantic proximity
Projecting the Transition of COVID-19 Burden Towards the Young Population While Vaccines are Rolled Out: A Modelling StudySemantic proximity
Select a neighboring publication to make it the new centre.